Beyond 2023: Exploring Nerve Repair Market Predictions 2033
Anticipated to surpass US$ 272.4 million in 2023, global nerve repair market sales are poised for a substantial 12.2% compound annual growth rate (CAGR) between 2023 and 2033, ultimately reaching an impressive US$ 861.4 million by 2033.
The increasing prevalence of neurological disorders, including Alzheimer’s and Parkinson’s disease, is driving the demand for nerve repair products, promising significant growth over the forecast period. Moreover, the market’s expansion will gain momentum thanks to continuous advancements in neurological treatments.
An illustrative example of this progress occurred in 2022 when Medtronic received approval from the United States Food and Drug Administration (FDA) for its Intellis neurostimulator and Vanta neurostimulator, aimed at treating chronic pain associated with diabetic peripheral neuropathy (DPN)
Click Here to Access Your Visuals-Packed Report!
https://www.futuremarketinsigh....ts.com/reports/sampl
The prevalence of various chronic nervous system diseases, including Parkinson’s and Alzheimer’s, is expected to increase throughout the projection period, which is also expected to drive up demand for treatments that heal damaged nerves. Also, it is anticipated that market expansion may quicken as a result of scientific developments in neurological therapies. Recent research indicate that there has been a sharp increase in incidences of nerve damage in industrialized nations, which has fueled the market’s demand. According to the American Association for Peripheral Nerve, 1.2 million treatments are carried out annually in the United States alone.
Key Takeaways:
Prominent market players in the global nerve repair market are keeping an eye on the East and South Asia markets in order to capitalize on the growing demand for neurological products combined with rising awareness in countries including India, China, and Japan. The key players are also tapping into the markets of Mexico, Indonesia, and other Middle Eastern nations. This is also expected to fuel the demand in the nerve repair market.
In addition, prominent producers in the market are investing heavily in streamlining their R&D and improving production for nerve repair products. Owing to the cost-effectiveness achieved by outsourcing their manufacturing capabilities, CDMOs will likely anticipate a profitable decade.
When there is a damaged nerve, it can lead to serious motor and sensory issues that are expected to ache and cause the appendages to malfunction. Therefore, health professionals employing biomaterials in the nerve repair process are included in products for nerve repair. The autograft is the gold standard for nerve repair procedures, although the specifics of the procedure are determined by the type and severity of the nerve injury.
Technologically advanced nerve repair therapies are utilized to efficiently treat damage brought on by trauma and several other factors, which is known as a key factor responsible for influencing the market. Adult stem cells can easily be extracted from adipose tissue, skin, and bone marrow, and are now being employed in many developed nations to repair and regenerate nerves.
Key players in the market are rising the manufacturing of nerve repair products as the prevalence of neurological disorders across the globe. Moreover, an increase in nerve repair expenditure is likely to drive sales in the nerve repair market over the forecast period (2022-2032).
An estimation of US$ 150 billion is predicted to have been spent on medical care for nerve injuries annually in the U.S. This showcases the expenditure on nerve repair, replacement, and regeneration due to a rise in cases of indications like amyotrophic lateral sclerosis, multiple system atrophy, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis.
Competitive Landscape:
With the establishment of several key nerve repair production companies all over the world, the overall market is anticipated to be highly fragmented. In order to maintain a strong foothold over the entire industry, key players are increasing R&D efforts to expand their novel product portfolios. Various products are still in the pipeline stage as the companies are proceeding toward promoting regularization and licensing of these pipelined products after assessing their efficacy.
More Insights into the Nerve Repair Market
The U.S. held approximately 89.5% share in the global nerve repair market in 2021, opines FMI. Sales in the U.S. are slated to grow at an impressive CAGR of 13.3% during the forecast period.
Key Companies Profiled
Axogen Inc.
Stryker Corporation
Baxter International Inc.
Integra Lifesciences Holdings Corp
Neurotex Ltd
Polyganics B.V.
Abbott Laboratories
Boston Scientific Inc
Medtronic Plc
Checkpoint Surgical
Polyganics
Synovis Micro Companies Alliance
Orthomed, Inc
Key Market Segments Covered in Nerve Repair Industry Research
By Product:
Nerve Wrap
Nerve Protector
Nerve Connector
Nerve Graft
By Nerve Repair:
Epineural Nerve Repair
Perineural Nerve Repair
Fascicular Nerve Repair
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)
1 (877) 773-1002